DEVELOPMENT AND CHARACTERIZATION OF QUINAPRIL CO-CRYSTALS USING NEUTRACEUTICALS AS CO-FORMERS

  • Unique Paper ID: 158977
  • Volume: 9
  • Issue: 11
  • PageNo: 97-101
  • Abstract:
  • The co-crystals of quinapril were developed by solvent evaporation method and using nutraceuticals as co-formers such as quercetin, nicotinic acid, curcumin, and caffeine in 1:2 equimolar ratio and observed effect on drug release pattern. The developed co-crystals were tested in pre and post-compression parameters. All formulation findings have been determined to be within pharmacopeial limits. The most significant percentage of drug release for 2 hrs was 99.84% in the optimized formulation (F1) compared with the marketed product (Accupril). The SEM studies showed that optimized formulation (F1) good uniformity as well as crystalline nature. The Higuchi model offers an R2 value of 0.983, indicating that the drug release was followed by non-fickian diffusion.
add_icon3email to a friend

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{158977,
        author = {Palle Maneesha and Thatikayala Ravi Kumar},
        title = {DEVELOPMENT AND CHARACTERIZATION OF QUINAPRIL CO-CRYSTALS USING NEUTRACEUTICALS AS CO-FORMERS},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {9},
        number = {11},
        pages = {97-101},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=158977},
        abstract = {The co-crystals of quinapril were developed by solvent evaporation method and using nutraceuticals as co-formers such as quercetin, nicotinic acid, curcumin, and caffeine in 1:2 equimolar ratio and observed effect on drug release pattern. The developed co-crystals were tested in pre and post-compression parameters. All formulation findings have been determined to be within pharmacopeial limits. The most significant percentage of drug release for 2 hrs was 99.84% in the optimized formulation (F1) compared with the marketed product (Accupril). The SEM studies showed that optimized formulation (F1) good uniformity as well as crystalline nature. The Higuchi model offers an R2 value of 0.983, indicating that the drug release was followed by non-fickian diffusion.},
        keywords = {Co-crystals, Quinapril, Co-formers, and Neutraceuticals},
        month = {},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 11
  • PageNo: 97-101

DEVELOPMENT AND CHARACTERIZATION OF QUINAPRIL CO-CRYSTALS USING NEUTRACEUTICALS AS CO-FORMERS

Related Articles

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now arrowright18x

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry arrowright18x